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Background: Paracetamol (also known as acetaminophen) is the commonest available analgesic and anti-pyretic. It
is readily accessed from pharmacy, patent medicine and provision shops as over the counter drug making it a
potential drug of abuse, especially in children. We sought to find its use and/or misuse in children seen at the
paediatric outpatient clinic of the University of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla, Enugu.
Objective: To determine the dosage, formulation, and frequency of paracetamol administration to children by
caregivers and factors associated with its use and/or misuse.
Method: An observational prospective study involving 231 children and their caregivers seen at the paediatric
outpatient clinic of the University of Nigeria Teaching Hospital, Ituku - Ozalla, Enugu between June and November
2011 was undertaken. Data on paracetamol use before presentation to the clinic, in addition to demographic and
other data were obtained from the caregivers using a structured questionnaire. Ethical consent for the study was
obtained from the Hospital Ethics and Research Committee and informed consent was further obtained from the
caregivers of the children.
Results: A total of 231 children aged six weeks to 16 years and their caregivers participated in this study. The mean
ages of the children and their caregivers were 3.8 and 33.9 years, respectively. One hundred and thirty three of the
children studied were males while 98 were females. Most of the children (75.6%) received paracetamol at home
before presenting. Paracetamol tablet alone or in combination with the syrup was mostly used (60%) and this
observation was made across all age groups. The commonest reason for using paracetamol tablet instead of the
syrup was that it was more effective. Most caregivers relied on past experience (71.2%) rather than on enclosed
information leaflet to decide the appropriate dosage. Half of the children also received other medications, mainly
anti-malarials and antibiotics.
Conclusions: Paracetamol was commonly given to children on “self prescription” basis and the tablet formulation
was most frequently used, with the possibility of misuse and overdose. Caregivers need to be educated on age-
appropriate formulations which are less likely to lead to overdose.
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Paracetamol (also known as acetaminophen) is the most
widely used analgesic and antipyretic [1]. It is found in
many over the counter and prescription products. Given
in the right dosage it is not associated with many side
effects; however prolonged use may produce renal injury
and massive overdose may produce hepatic injury [1]. It* Correspondence: herbert.obu@unn.edu.ng
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reproduction in any medium, provided the oris the most common pharmaceutical agent involved in
overdose particularly below the age of 6 years [2,3].
There is a particularly significant risk of paracetamol
overdose in infants and children because of the varying
dosing schedules and the variety of formulations with
different strengths [3]. The easiest way to inadvertently
overdose on paracetamol is to combine various cough,
cold and teething medications because people are un-
aware that paracetamol is contained in most of them [4].
Paracetamol is a weak inhibitor of the synthesis of
prostaglandins. The in vivo effects of the drug are simi-
lar to those of selective cyclooxygenase −2 inhibitors [5].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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side effects can occur when used inappropriately. Liver
injury secondary to repeated dosing of paracetamol
should be considered when a child has received more
than 75 mg/kg/day for at least 2 days or if risk factors
for paracetamol toxicity exist [6].
Paracetamol abuse is said to have increased 5- folds
between 1978 and 1988, and has worsened to more than
200 g/person/year in the US [7]. In the United Kingdom,
the rate at which paracetamol is purchased without pre-
scription is reported to have increased to 3500 million
500 mg tablets in the year 2000 [8]. Paracetamol over-
dose is a significant cause of hospital admission in the
US but severe liver damage is infrequent and when it
occurs the prognosis is good [8].
This study sought to assess patterns of paracetamol
use and/or misuse and associated factors in children in
Enugu, South-East Nigeria. To the best of our know-
ledge there is a dearth of published work on paracetamol
use in the area and in Nigeria in general. It is hoped that
this study may shed more light on the subject with a
view to encouraging rational use of this common
pharmaceutical agent in children.
Methods
Study area
The study was conducted at the paediatric outpatient
clinics of the University of Nigeria Teaching Hospital
(UNTH) Ituku-Ozalla, Enugu; a tertiary health institu-
tion located about 20 km from the city of Enugu in
south-eastern Nigeria. The hospital receives referrals
from various health facilities in Enugu State and the
neighboring states of Anambra, Ebonyi, Benue, Imo and
Abia.
Study population
An observational prospective study involving 231 chil-
dren aged 6 weeks to 16 years and their caregivers seen
at the paediatric outpatient clinic of the University of
Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, between
June and November 2011, was carried out using con-
venient sampling method. All children attending the
paediatric clinic of the hospital during the period of the
study and who satisfied the inclusion criteria were con-
secutively enrolled.
Study procedure
A structured self administered questionnaire was used
to collect information from the caregivers of children
(and older children who came unaccompanied) attend-
ing the paediatric outpatient clinic of the hospital during
the study period. In a few cases where the caregivers/
children were illiterate, the questionnaire was adminis-
tered to them by the investigators who help to clear alldifficulty that may arise from filling the questionnaire.
Information sought included socio-demographic charac-
teristics, paracetamol use before presenting (including
dosage, dosing interval, type of formulation used, indica-
tions, and source of prescription, etc.) and other medica-
tions given.
Efforts were made to confirm that the children actually
received paracetamol, and not any other medicine, by
showing the caregivers different formulations and packs
of the drug used in our locale and these were easily
identified.
Paracetamol over dose was assessed based on the fre-
quency of administration or dose administered. A his-
tory of frequency of administration that exceeded four
times in a 24 hour period was regarded as abuse [9].
The following dosage criteria were used to ascertain if
the caregiver was giving excess dose. A dose that
exceeded 10 mg/kg for children under 3 months, more
than 60 mg to 120 mg (2.5 mL to 5 mL of oral suspen-
sion) for those children 3 months to 1 year of age, more
than 120 mg to 250 mg (5 mL to 10 mL of oral suspen-
sion) for those aged 1 to 5 years, more than 250 mg to
500 mg for those aged 6 to 12 years of age and more
than 1000 mg for those above 12 years [9].
Inclusion criteria
Children aged between 6 weeks and 16 years and those
in whom informed consent was obtained were included
in the study.
Exclusion criteria
Severely ill children Subjects and those unwilling to par-
ticipate in the study were excluded.
Data analysis
Data was analyzed with SPSS version 19. An initial fre-
quency count of all variables was done and represented
in tables. The ages and sex of the children were com-
pared using Chi square test. Chi square test was also
used to compare the relationship between age and for-
mulation of paracetamol administered. The mean and
ranges of all the variables were calculated. The level of
significance was set at p ≤ 0.05.
Ethical considerations
Ethical clearance for the study was obtained from the
Ethics and Research Committee of the University of Ni-
geria Teaching Hospital. A written informed consent
was further obtained from the caregivers and older
children.
Aim
To determine the pattern of paracetamol administration
in children in Enugu, South-East Nigeria.
Table 2 Reasons for Administering Paracetamol
Symptom Frequency (%)
Fever 145 (62.7)
Cough and/or Catarrh 17 (7.4)
Abdominal pain/discomfort 9 (3.9)
Ear ache 8 (3.5)
Skin rash 6 (2.6)
Generalized body pains 5 (2.2)
Fast/difficulty in breathing 4 (1.7)
Convulsions 3 (1.3)
Others (injury, tooth ache, excessive crying, vomiting) 6 (2.6)
No Response 28(12.1)
Total 231
Table 3 Relationship between age and formulation of
Paracetamol administered
Age (yrs) Less than 5 (%) 5-10 11-16 (%)
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1. To determine the pattern of paracetamol use and/or
misuse in children in Enugu, South-East Nigeria.
2. To determine the factors associated with
paracetamol use and/or misuse in children.
Results
Demography
A total of 231 children were enrolled into this study.
One hundred and thirty three were males while 98 were
females giving a male: female ratio of 1: 0.7. The chil-
dren were aged 6 weeks to 16 years. The mean age of
the children was 3.8 ± 4.3 years. The most common age
group in this study was under five years which repre-
sented 67.7% and 72.4% of males and females respect-
ively. There was no statistically significant difference in
age distribution of the children in relation to their sex as
shown in Table 1.
The Caregivers were aged 18 to 57 years. Most of
them 208 (90.3%) were females. The highest educational
attainment of majority of the Caregivers151 (65.3%) was
first degree of diploma. The rest had senior secondary
66 (28.6%), primary 7 (2.8%), junior secondary 3 (1.4%)
and post graduate education 3 (1.4%), 1 (0.5%) did not
indicate level of education. The various occupation of
the Caregivers were civil servants 59 (25.6%), un-
employed 58 (25.1%), trading 33 (14.4%), teaching 30
(13%), self-employed 18 (7.9%), health care worker 15
(6.5%), banker/marketer 9 (3.7%) and others 9 (3.8%).
Among the Caregivers, 205 (88.7%) were mothers of the
children, 16 (7%) were fathers, 4 (1.7%) aunts and 6
(2.6%) others (such as uncles, sisters, brothers).
Paracetamol use
Most of the children 175 (75.6%) received Paracetamol
at home before presenting at the Clinic. Among them,
the most reason for administering Paracetamol was fever
158 (68.4%). Other reasons were headache, abdominal
pain or discomfort, cough as shown in Table 2.
Except for two children 3 (1.1%) that received inject-
able paracetamol, oral administration was the preferred
route 228 (98.9%). The oral formulations used, were tab-
let 114 (49.2%), syrup 89 (38.7%) while 28 (12.1%)
received both tablet and syrup.Table 1 Age and sex distribution of the children
Age of Clients (years) Male (%) Female (%)
Less than 5 90 (67.7) 71 (72.4)
5-10 30 (22.6) 17 (17.3)
11-16 13 (9.7) 10 (10.3)
Total 133 (100) 98 (100)
χ² = .948, df =2, p = 0. 623.Among children under the age of five, syrup formula-
tion was most commonly used 64 (39.8%) while tablet
was most commonly used among those aged 5–10 years
28 (59.5%) and 11 to 16 years 12 (52.2%) as shown in
Table 3. There was a statistically significant difference
between the age groups of the children and formulation
used.
Almost half of the respondents (45.0%) decided on
their own to administer paracetamol to their children.
The rest received prescription from a doctor (20.0%), a
nurse (6.5%) and from either a Patent Medicine Dealer
or a Pharmacist (4.3%) as shown in Table 4. Most of
them (71.2%) relied on past experience to arrive at the
dose to be administered as shown in Table 5.
Paracetamol misuse was found in only a total of 4
(1.7%) cases, majority of them are aged between 6 weeks
−5 years as shown in Table 6 below. Adequate dosing
and frequency of paracetamol was practiced by majority
of the respondent for the different age groups; however
72(31.1%) of the respondent were silent on that
question.
Discussion
Most of the children described in this study received
paracetamol, especially to treat febrile episodes. ThisAge of Clients (%)
(years)
Tablet 45(28.0) 28 (59.5) 12 (52.2)
Syrup 64 (39.8) 2 (4.3) 0 (0)
tablet and syrup 18 (11.2) 2 (4.3) 1 (4.3)
No response 34 (21.0) 15(31.9) 10(43.5)
Total 161(100) 47(100) 23 (100)
χ² = 39.2, df =4, p = 0. 00.




Patent Medicine Dealer/Pharmacist 10 (4.3)
Self. 104 (45.0)
No response 56 (24.2)
Total 231 (100%)
Table 6 Dose and frequency of paracetamol
administration distributed according to the age groups






2.5 ml 34 0 0 34
≤4 times 3 0 0 3
>4 times
5 ml 2 1 0 3




22 1 23 46
≤4 times 0 0 0 0
>4 times
1 tablet (500 mg) 31 22 3 56
≤4 times 1 1 0 2
>4 times
1 and 1/2 tablets 0 0 1 1
≤4 times 0 0 0 0
>4 times
2 tablets 2 4 8 14
≤4 times 0 0 0 0
>4 times
Total 95 29 35 159
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anti- pyretic) to children with fever does not appear to
have any benefits from available studies [10,11]. Fever is
a common symptom of childhood illness in both devel-
oped and developing countries and much time and effort
is spent on attempts to reduce high temperatures in
young children. Though the disease process that leads to
fever may be harmful, no convincing evidence shows
that fever is harmful; despite this; many parents and
physician believe that antipyretic treatment improves fe-
brile children discomfort and behavior [12]. The current
guidelines of WHO on the management of fever recom-
mends the use of paracetamol for children with a
fever ≥ 390 C but many a time at temperatures much
lower than this value, paracetamol or other antipyretics
are given in our setting. There is however insufficient
data to support this practice. In a Cochrane review in
which the antipyretic effect of paracetamol was com-
pared with that of a placebo, no clear advantage of para-
cetamol over the placebo was demonstrated [12].
It is observed that most of the paracetamol adminis-
tered to our children in this study were self prescribed
with a possible tendency of misuse. The reasons for this
observation are not quite clear but easy availability/ac-
cessibility of the drug, ignorance and poverty may have
contributed.
Park [5] reported a growing concern over the drugs
which can be given to children without prescription
when parents may not be fully aware of the potential
risks. It is pertinent to note that [13] in the United King-
dom the rate of paracetamol purchased without pre-
scription is reported to have increased to 3500 million
500 mg tablets in the year 2000 [14].
Majority of the caregivers in our setting prefer tablet
to syrup formulations of paracetamol. The reason for
this is not obvious but the belief by some people that
tablet formulations are more efficacious than syrups mayTable 5 Determination of dose administered
Method of dose determination Frequency (%)
Directions on the medication 29 (26.1)
Past experience 79 (71.2)
Health care workers 3(2.7)be tenable here. From our knowledge of pharmacology,
there should be no difference in efficacy between tablets
and syrups when properly formulated. Hundie and col-
leagues in their study made similar observations [15].
A greater percentage of the caregivers gave paraceta-
mol to their children via the oral route. Whereas
Remsing [16] and co-workers in their series noted that
parenteral paracetamol had a more rapid onset of action,
however, oral formulations are safe, well absorbed and
equally efficacious and should be promoted.
Majority of caregivers in our study gave paracetamol
in correct doses to their children. This could be
explained by the fact that most of them are educated
[63%] and well informed. The use of paracetamol in
therapeutic doses is generally safe although hepatotox-
icity has occurred with recommended dosages in chil-
dren in developing countries [16].
This study reiterates the fact that majority of child-
hood febrile illnesses are first treated at home using past
experience as a guide. This is not surprising as no care-
giver worth his salt will sit put and watch his sick child
in pain and/or discomfort without doing anything. It
was also suggested that it gives the child rest and sleep
and enables the family to rest too [17]. In a cross-
sectional survey by Ajayi et al. [18] involving 535
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in an outpatient clinic, paracetamol and chloroquine
were the most commonly used drugs before presentation
to the hospital. This is in consonance with our findings
and underscores the need to empower caregivers by ap-
propriate education.
Conclusion
Paracetamol is an invaluable over-the-counter medica-
tion which is safe, readily available and affordable;
though given in appropriate dose in this study, however,
it has great potential for misuse and overdose.
Recommendation
More education concerning paracetamol should be given
to caregivers and older children on its appropriate dos-
ing to avoid serious adverse events when given
inappropriately.
Limitation
A population based study or one carried out in a pri-
mary health care rather than hospital based may give a
better picture of paracetamol use and/or misuse.
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